286 related articles for article (PubMed ID: 23029380)
1. MicroRNA expression profiles of whole blood in lung adenocarcinoma.
Patnaik SK; Yendamuri S; Kannisto E; Kucharczuk JC; Singhal S; Vachani A
PLoS One; 2012; 7(9):e46045. PubMed ID: 23029380
[TBL] [Abstract][Full Text] [Related]
2. Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
Patnaik SK; Kannisto ED; Mallick R; Vachani A; Yendamuri S
PLoS One; 2017; 12(7):e0181926. PubMed ID: 28742859
[TBL] [Abstract][Full Text] [Related]
3. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.
Sun Y; Mei H; Xu C; Tang H; Wei W
Pathol Res Pract; 2018 Jan; 214(1):119-125. PubMed ID: 29103767
[TBL] [Abstract][Full Text] [Related]
5. Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma.
Wang Y; Zhao H; Gao X; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
Oncotarget; 2016 May; 7(18):26070-86. PubMed ID: 27036025
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
7. Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
Roth C; Stückrath I; Pantel K; Izbicki JR; Tachezy M; Schwarzenbach H
PLoS One; 2012; 7(6):e38248. PubMed ID: 22675530
[TBL] [Abstract][Full Text] [Related]
8. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer.
Cazzoli R; Buttitta F; Di Nicola M; Malatesta S; Marchetti A; Rom WN; Pass HI
J Thorac Oncol; 2013 Sep; 8(9):1156-62. PubMed ID: 23945385
[TBL] [Abstract][Full Text] [Related]
9. Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients.
Gao F; Chang J; Wang H; Zhang G
Oncol Rep; 2014 Jan; 31(1):351-7. PubMed ID: 24190459
[TBL] [Abstract][Full Text] [Related]
10. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
Yu L; Todd NW; Xing L; Xie Y; Zhang H; Liu Z; Fang H; Zhang J; Katz RL; Jiang F
Int J Cancer; 2010 Dec; 127(12):2870-8. PubMed ID: 21351266
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
14. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression differentiates histology and predicts survival of lung cancer.
Landi MT; Zhao Y; Rotunno M; Koshiol J; Liu H; Bergen AW; Rubagotti M; Goldstein AM; Linnoila I; Marincola FM; Tucker MA; Bertazzi PA; Pesatori AC; Caporaso NE; McShane LM; Wang E
Clin Cancer Res; 2010 Jan; 16(2):430-41. PubMed ID: 20068076
[TBL] [Abstract][Full Text] [Related]
16. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
[TBL] [Abstract][Full Text] [Related]
18. miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung.
Kim HK; Lim NJ; Jang SG; Lee GK
Anticancer Res; 2014 May; 34(5):2297-302. PubMed ID: 24778034
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues.
Guan P; Yin Z; Li X; Wu W; Zhou B
J Exp Clin Cancer Res; 2012 Jun; 31(1):54. PubMed ID: 22672859
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
